Atlas Trials

A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer

Clinical trial NCT03705429 · COMPLETED

Trial details

NCT number
NCT03705429
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2019-05-01
Primary completion
2022-05-11
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.